BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 6155401)

  • 1. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of antigen- and mitogen-induced T cells on various targets.
    Bevan MJ; Cohn M
    J Immunol; 1975 Feb; 114(2 Pt 1):559-65. PubMed ID: 123541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 7. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice.
    Smith JB; Pasternak RD
    J Immunol; 1978 Nov; 121(5):1889-92. PubMed ID: 152331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical enhancement of tumor immunogenicity.
    Eggers AE; Hibbard CA; Civin CI; Wunderlich JR
    J Immunol; 1980 Oct; 125(4):1737-44. PubMed ID: 6967915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological status of nude mice engrafted with allogeneic or syngeneic thymuses.
    Furukawa F; Ikehara S; Good RA; Nakamura T; Inoue S; Tanaka H; Imamura S; Hamashima Y
    Thymus; 1988; 12(1):11-26. PubMed ID: 2977452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
    Teh HS; Yu M
    J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
    Gautam SC; Deodhar SD
    Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors.
    Boyer PJ; Fahey JL
    J Immunol; 1976 Jan; 116(1):202-9. PubMed ID: 128571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
    Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
    J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.